Our forward-thinking panel of local leaders will discuss the vision for Tri-Valley, a thriving Bay Area innovation hub. The ...

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

BMO Capital keeps an Outperform rating Gilead (GILD) after the Wall Street Journal reported that Robert F. Kennedy Jr. plans ...

Merck (MRK) is cutting $3 billion from its annual expenses as it prepares for generic competition to its blockbuster cancer drug, Keytruda.

Merck (NYSE:MRK) is cutting $3 billion from its annual expenses as it prepares for generic competition to its blockbuster ...

In an uncertain market, dividend stocks stand out. Companies that provide consistent dividends prove they can provide reliable profits from their operations, which is perhaps just as important to ...